Pomona, CA…Imagine technology so advanced that it helps patients
who have had a stroke or other neurological impairment to regain mobility
and walk again – an ability that these individuals believed to be
More than 700,000 people suffer a stroke every year, with two-thirds of
those individuals surviving and requiring intensive rehabilitation. These
stroke and other neurological patients are regaining lost mobility and
achieving greater independence thanks to advanced technology just released
by Bioness ® Inc. and offered at
Casa Colina Centers for Rehabilitation in Pomona, CA. Individuals who have experienced stroke, traumatic brain injury, multiple
sclerosis, cerebral palsy, and incomplete spinal cord injury are primary
candidates for the new technology and are talking about improvements in
quality of life as a result of using the
Bioness NESS L300™.
Casa Colina patient, Simon Lewis, a stroke survivor from Sherman Oaks,
CA, says he is now able to walk without a cane for the first time in 13
years, and the L300 is giving him the confidence to take his driver’s
test. Dr. David Patterson, Medical Director of Casa Colina Hospital where
Simon received his evaluation and physical therapy, believes that integrating
the L300 into its standard of care increases Casa Colina Hospital’s
capability to improve patient outcomes. “With this new technology,
patients can advance to greater independence in what they do in their
home and their community,” says Dr. Patterson.
Casa Colina is among the first in the country and the first in California
to offer this breakthrough adjunctive therapy and will serve as a regional
assessment site for patients interested in trying out the new device.
Please contact Casa Colina Hospital’s Outpatient Center for more
information about the use of the L300 or to schedule an evaluation. Call
909/596-7733 or toll-free 800/926-5462, Ext. 3500. To learn more about
Casa Colina, please visit www.casacolina.org.
About the NESS L300™.
Central nervous system injuries like stroke often result in foot drop—leading
to instability and difficulty walking. The NESS L300™ neuro-rehabilitation
system is a major advancement in Functional Electrical Stimulation (FES)
technology, designed to help patients experiencing foot drop to regain
mobility and help “normalize” walking and gait. The L300 uses
wireless communication to “talk” to its components, eliminating
cumbersome wires and allowing the clinician ability to fine-tune settings
while the patient is actually walking. This user-friendly system is appropriate
for a broad range of conditions, including stroke, traumatic brain injury,
multiple sclerosis, cerebral palsy and incomplete spinal cord injury.
It is being used in hospital, outpatient and home settings.
About Bioness Inc.
California-based Bioness Inc. was formed in 2004 by the Alfred E. Mann,
a leading medical device entrepreneur, the Alfred Mann Foundation for
Scientific Research, a world leader in medical device technology, and
NESS Ltd., a company headquartered in Israel that develops and manufactures
neuroprosthetic and rehabilitation systems. Bioness Inc.’s mission
is to deliver innovative devices and therapies to the field of physical
medicine, taking rehabilitation to new levels of physical independence
and productivity. Release of the L300 follows introduction of the
NESS H200™, another Bioness technology designed to advance upper extremity rehabilitation.
To learn more about the NESS L300 and to access patient footage and interviews,